PET and MRI in cardiac imaging: From validation studies to integrated applications

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 36, Issue SUPPL. 1, 2009, Pages 121-130

  Nekolla, Stephan G ^a   Martinez Moeller, Axel ^a   Saraste, Antti ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Cardiac imaging; Hybrid PET MRI; MRI; PET

Indexed keywords

ANGIOCARDIOGRAPHY; ATHEROSCLEROTIC PLAQUE; CARDIOLOGY; CELL VIABILITY; CORONARY ARTERY; CORONARY ARTERY DISEASE; GOLD STANDARD; HEART; HEART FAILURE; HEART INFARCTION; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE PERFORMANCE; HEART MUSCLE PERFUSION; HEART VENTRICLE FUNCTION; HUMAN; HYBRID; IMAGING AND DISPLAY; INTERMETHOD COMPARISON; NON INVASIVE PROCEDURE; NUCLEAR MAGNETIC RESONANCE IMAGING; PERFORMANCE; POSITRON EMISSION TOMOGRAPHY; QUALITY CONTROL; REVIEW; STEM CELL TRANSPLANTATION; VALIDATION STUDY;

ANIMALS; HEART; HEART DISEASES; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; POSITRON-EMISSION TOMOGRAPHY; VALIDATION STUDIES AS TOPIC;

EID: 60649120728     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-008-0980-1     Document Type: Review

References (58)

1. FJ Klocke MG Baird BH Lorell TM Bateman JV Messer DS Berman 2003 ACC/AHA/ASNC guidelines for the clinical use of cardiac radionuclide imaging - executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASNC Committee to Revise the 1995 Guidelines for the Clinical Use of Cardiac Radionuclide Imaging) J Am Coll Cardiol 42 1318 1333
2. RL Eisner RE Patterson 2007 Attenuation correction for stress and rest PET 82Rb myocardial perfusion images J Nucl Med 48 1912 1913
3. KC Allman LJ Shaw R Hachamovitch JE Udelson 2002 Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis J Am Coll Cardiol 39 1151 1158
4. K Swedberg J Cleland H Dargie H Drexler F Follath M Komajda 2005 Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology Eur Heart J 26 1115 1140
5. T Beyer DW Townsend T Brun PE Kinahan M Charron R Roddy 2000 A combined PET/CT scanner for clinical oncology J Nucl Med 41 1369 1379
6. M Naghavi P Libby E Falk SW Casscells S Litovsky J Rumberger 2003 From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I Circulation 108 1664 1672
7. A Martinez-Moller D Zikic RM Botnar RA Bundschuh W Howe SI Ziegler 2007 Dual cardiac-respiratory gated PET: implementation and results from a feasibility study Eur J Nucl Med Mol Imaging 34 1447 1454
8. MD Cerqueira NJ Weissman V Dilsizian AK Jacobs S Kaul WK Laskey 2002 Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association Int J Cardiovasc Imaging 18 539 542
9. T Makela P Clarysse O Sipila N Pauna QC Pham T Katila 2002 A review of cardiac image registration methods IEEE Trans Med Imaging 21 1011 1021
10. S Sinha U Sinha J Czernin G Porenta HR Schelbert 1995 Noninvasive assessment of myocardial perfusion and metabolism: feasibility of registering gated MR and PET images AJR Am J Roentgenol 164 301 307
11. Mäkela T, Clarysse P, Lötjönen J, Sipilä O, Lauerma K, Hänninen H, et al. A new method for the registration of cardiac PET and MR images using deformable model based segmentation of the main thorax structures. In: Niessen W, Viergever M, editors. Medical image computing and computer-assisted intervention - MICCAI 2001. Lecture Notes in Computer Science, vol. 2208. 4th International Conference, Utrecht, The Netherlands, October 14-17, 2001. Heidelberg: Springer; 2001. p. 557-64.
12. A Martinez-Moller M Souvatzoglou N Navab M Schwaiger SG Nekolla 2007 Artifacts from misaligned CT in cardiac perfusion PET/CT studies: frequency, effects, and potential solutions J Nucl Med 48 188 193
13. KL Gould T Pan C Loghin NP Johnson A Guha S Sdringola 2007 Frequent diagnostic errors in cardiac PET/CT due to misregistration of CT attenuation and emission PET images: a definitive analysis of causes, consequences, and corrections J Nucl Med 48 1112 1121
14. M Souvatzoglou F Bengel R Busch C Kruschke H Fernolendt D Lee 2007 Attenuation correction in cardiac PET/CT with three different CT protocols: a comparison with conventional PET Eur J Nucl Med Mol Imaging 34 1991 2000
15. DA Bluemke S Achenbach M Budoff TC Gerber B Gersh LD Hillis 2008 Noninvasive coronary artery imaging: magnetic resonance angiography and multidetector computed tomography angiography: a scientific statement from the american heart association committee on cardiovascular imaging and intervention of the council on cardiovascular radiology and intervention, and the councils on clinical cardiology and cardiovascular disease in the young Circulation 118 586 606
16. K Yoshinaga BJ Chow K Williams L Chen RA deKemp L Garrard 2006 What is the prognostic value of myocardial perfusion imaging using rubidium-82 positron emission tomography? J Am Coll Cardiol 48 1029 1039
17. TH Marwick K Shan S Patel RT Go MS Lauer 1997 Incremental value of rubidium-82 positron emission tomography for prognostic assessment of known or suspected coronary artery disease Am J Cardiol 80 865 870
18. S Sawada O Muzik RS Beanlands E Wolfe GD Hutchins M Schwaiger 1995 Interobserver and interstudy variability of myocardial blood flow and flow-reserve measurements with nitrogen 13 ammonia-labeled positron emission tomography J Nucl Cardiol 2 413 422
19. PA Kaufmann T Gnecchi-Ruscone JT Yap O Rimoldi PG Camici 1999 Assessment of the reproducibility of baseline and hyperemic myocardial blood flow measurements with 15O-labeled water and PET J Nucl Med 40 1848 1856
20. G El Fakhri A Sitek B Guerin MF Kijewski MF Di Carli SC Moore 2005 Quantitative dynamic cardiac 82Rb PET using generalized factor and compartment analyses J Nucl Med 46 1264 1271
21. M Schwaiger J Melin 1999 Cardiological applications of nuclear medicine Lancet 354 661 666
22. WJ Manning DJ Atkinson W Grossman S Paulin RR Edelman 1991 First-pass nuclear magnetic resonance imaging studies using gadolinium-DTPA in patients with coronary artery disease J Am Coll Cardiol 18 959 965
23. KR Nandalur BA Dwamena AF Choudhri MR Nandalur RC Carlos 2007 Diagnostic performance of stress cardiac magnetic resonance imaging in the detection of coronary artery disease: a meta-analysis J Am Coll Cardiol 50 1343 1353
24. J Schwitter CM Wacker AC van Rossum M Lombardi N Al-Saadi H Ahlstrom 2008 MR-IMPACT: comparison of perfusion-cardiac magnetic resonance with single-photon emission computed tomography for the detection of coronary artery disease in a multicentre, multivendor, randomized trial Eur Heart J 29 480 489
25. J Schwitter T DeMarco S Kneifel GK von Schulthess MC Jorg H Arheden 2000 Magnetic resonance-based assessment of global coronary flow and flow reserve and its relation to left ventricular functional parameters: a comparison with positron emission tomography Circulation 101 2696 2702
26. T Ibrahim SG Nekolla K Schreiber K Odaka S Volz J Mehilli 2002 Assessment of coronary flow reserve: comparison between contrast-enhanced magnetic resonance imaging and positron emission tomography J Am Coll Cardiol 39 864 870
27. L Sharples V Hughes A Crean M Dyer M Buxton K Goldsmith 2007 Cost-effectiveness of functional cardiac testing in the diagnosis and management of coronary artery disease: a randomised controlled trial. The CECaT trial. Health Technol Assess 11 iii iv
28. WY Kim PG Danias M Stuber SD Flamm S Plein E Nagel 2001 Coronary magnetic resonance angiography for the detection of coronary stenoses N Engl J Med 345 1863 1869
29. E Larose Y Yeghiazarians P Libby EK Yucel M Aikawa DF Kacher 2005 Characterization of human atherosclerotic plaques by intravascular magnetic resonance imaging Circulation 112 2324 2331
30. WY Kim M Stuber P Bornert KV Kissinger WJ Manning RM Botnar 2002 Three-dimensional black-blood cardiac magnetic resonance coronary vessel wall imaging detects positive arterial remodeling in patients with nonsignificant coronary artery disease Circulation 106 296 299
31. P Libby 2002 Inflammation in atherosclerosis Nature 420 868 874
32. JH Rudd EA Warburton TD Fryer HA Jones JC Clark N Antoun 2002 Imaging atherosclerotic plaque inflammation with [18F]-fluorodeoxyglucose positron emission tomography Circulation 105 2708 2711
33. J Sanz ZA Fayad 2008 Imaging of atherosclerotic cardiovascular disease Nature 451 953 957
34. G Germano H Kiat PB Kavanagh M Moriel M Mazzanti HT Su 1995 Automatic quantification of ejection fraction from gated myocardial perfusion SPECT J Nucl Med 36 2138 2147
35. A Khorsand S Graf H Frank K Kletter H Sochor G Maurer 2003 Model-based analysis of electrocardiography-gated cardiac (18)F-FDG PET images to assess left ventricular geometry and contractile function J Nucl Med 44 1741 1746
36. WM Schaefer CS Lipke B Nowak HJ Kaiser P Reinartz A Buecker 2004 Validation of QGS and 4D-MSPECT for quantification of left ventricular volumes and ejection fraction from gated 18F-FDG PET: comparison with cardiac MRI J Nucl Med 45 74 79
37. NG Bellenger LC Davies JM Francis AJ Coats DJ Pennell 2000 Reduction in sample size for studies of remodeling in heart failure by the use of cardiovascular magnetic resonance J Cardiovasc Magn Reson 2 271 278
38. FM Bengel J Lehnert T Ibrahim C Klein HP Bulow SG Nekolla 2003 Cardiac oxidative metabolism, function, and metabolic performance in mild hyperthyroidism: a noninvasive study using positron emission tomography and magnetic resonance imaging Thyroid 13 471 477
39. AF Schinkel D Poldermans A Elhendy JJ Bax 2007 Assessment of myocardial viability in patients with heart failure J Nucl Med 48 1135 1146
40. RJ Kim DS Fieno TB Parrish K Harris EL Chen O Simonetti 1999 Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function Circulation 100 1992 2002
41. C Klein SG Nekolla T Balbach B Schnackenburg E Nagel E Fleck 2004 The influence of myocardial blood flow and volume of distribution on late Gd-DTPA kinetics in ischemic heart failure J Magn Reson Imaging 20 588 593
42. C Klein TR Schmal SG Nekolla B Schnackenburg E Fleck E Nagel 2007 Mechanism of late gadolinium enhancement in patients with acute myocardial infarction J Cardiovasc Magn Reson 9 653 658
43. C Klein SG Nekolla FM Bengel M Momose A Sammer F Haas 2002 Assessment of myocardial viability with contrast-enhanced magnetic resonance imaging: comparison with positron emission tomography Circulation 105 162 167
44. RJ Kim E Wu A Rafael EL Chen MA Parker O Simonetti 2000 The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction N Engl J Med 343 1445 1453
45. HP Kuhl CS Lipke GA Krombach M Katoh TF Battenberg B Nowak 2006 Assessment of reversible myocardial dysfunction in chronic ischaemic heart disease: comparison of contrast-enhanced cardiovascular magnetic resonance and a combined positron emission tomography-single photon emission computed tomography imaging protocol Eur Heart J 27 846 853
46. BL Gerber CE Rochitte DA Bluemke JA Melin P Crosille LC Becker 2001 Relation between Gd-DTPA contrast enhancement and regional inotropic response in the periphery and center of myocardial infarction Circulation 104 998 1004
47. M Schmidt E Voth CA Schneider P Theissen R Wagner FM Baer 2004 F-18-FDG uptake is a reliable predictory of functional recovery of akinetic but viable infarct regions as defined by magnetic resonance imaging before and after revascularization Magn Reson Imaging 22 229 236
48. T Higuchi SG Nekolla A Jankaukas AW Weber MC Huisman S Reder 2007 Characterization of normal and infarcted rat myocardium using a combination of small-animal PET and clinical MRI J Nucl Med 48 288 294
49. F Haas CJ Haehnel W Picker S Nekolla S Martinoff H Meisner 1997 Preoperative positron emission tomographic viability assessment and perioperative and postoperative risk in patients with advanced ischemic heart disease J Am Coll Cardiol 30 1693 1700
50. RY Kwong AK Chan KA Brown CW Chan HG Reynolds S Tsang 2006 Impact of unrecognized myocardial scar detected by cardiac magnetic resonance imaging on event-free survival in patients presenting with signs or symptoms of coronary artery disease Circulation 113 2733 2743
51. FM Bengel M Schwaiger 2004 Assessment of cardiac sympathetic neuronal function using PET imaging J Nucl Cardiol 11 603 616
52. HJ Verberne LM Brewster GA Somsen BL van Eck-Smit 2008 Prognostic value of myocardial 123I-metaiodobenzylguanidine (MIBG) parameters in patients with heart failure: a systematic review Eur Heart J 29 1147 1159
53. T Sasano MR Abraham KC Chang H Ashikaga KJ Mills DP Holt 2008 Abnormal sympathetic innervation of viable myocardium and the substrate of ventricular tachycardia after myocardial infarction J Am Coll Cardiol 51 2266 2275
54. R Haubner WA Weber AJ Beer E Vabuliene D Reim M Sarbia 2005 Noninvasive visualization of the activated alphavbeta3 integrin in cancer patients by positron emission tomography and [18F]Galacto-RGD PLoS Med 2 e70
55. T Higuchi FM Bengel S Seidl P Watzlowik H Kessler R Hegenloh 2008 Assessment of alphavbeta3 integrin expression after myocardial infarction by positron emission tomography Cardiovasc Res 78 395 403
56. Makowski MR, Ebersberger U, Nekolla S, Schwaiger M. In vivo molecular imaging of angiogenesis, targeting {alpha}v{beta}3 integrin expression, in a patient after acute myocardial infarction. Eur Heart J. 2008 Mar 27.
57. SJ Zhang JC Wu 2007 Comparison of imaging techniques for tracking cardiac stem cell therapy J Nucl Med 48 1916 1919
58. FM Bengel M Anton T Richter MV Simoes R Haubner J Henke 2003 Noninvasive imaging of transgene expression by use of positron emission tomography in a pig model of myocardial gene transfer Circulation 108 2127 2133